A Study on Prescribing Pattern of Antihypertensive drugs in Diabetic patients at a tertiary care teaching hospital

Authors

  • Preeti Singhai Assistant Professor, Department of Medicine, Ananta Institute of Medical Sciences & Research Centre, Rajsamand Author

DOI:

https://doi.org/10.21276/bet73961

Keywords:

Diabetes, Hypertension, Antihypertensive drugs, Angiotensin receptor blocker

Abstract

Background: Patients with diabetes has 2 fold higher chances of suffering from hypertension. Hypertension is risk factor for development of diabetes as well for complications like nephropathy, CAD and neuropathy etc. Hypertension control is vital to prevent and retard progression of microvascular and macrovascular complications. Therefore, we undertook this study to evaluate treatment patterns in diabetic patients with hypertension, those are being followed at our institute.

Methods: This study was conducted on diabetic patients who had hypertension as well. Prescribing Pattern of Antihypertensive drugs was analysed on all diabetic patients reporting to medicine OPD at our institute were screened.  Results: Out of n=446 patients, 242 were males and 204 were females. Mean age of group was 48.6 years. 46.18% patients were on monotherapy and remaining patients were on combination antihypertensive drugs. There were total 796 antihypertensive drug exposures. Patient needed mean antihypertensive drug of 1.78. Angiotensin receptor blockers were the most commonly prescribed drugs. Angiotensin inhibitors (angiotensin receptor blockers and ACE inhibitors) were utilized in 71% patients. Hypertension control was achieved in 37.66% patients. About 81.2%) aware about disease.

ConclusionsOur study showed that majority of diabetic hypertensive patients needed multiple drug therapy to control hypertension. Most of the patients were on ARBs/ACE inhibitors. This was according to recommendation by ADA or JNC8.

Downloads

Download data is not yet available.

References

Sicree R, Shaw J, Zimmet P. Diabetes and impaired glucose tolerance.

In: Gan D, eds. Diabetes Atlas. International Diabetes Federation. 3rd

ed. Brussels, Belgium: International Diabetes Federation; 2006: 15-103.

Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J.

Global burden of hypertension: analysis of worldwide data. Lancet.

;365(9455):217-23.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of

diabetes: estimates for the year 2000 and projections for 2030. Diabetes

Care. 2004;27(5):1047-53.

National Institutes of Health. Diabetes in America. In: NIH, eds. National

Institutes of Diabetes and Digestive and Kidney Diseases. 2nd ed.

Bethesda, MD: NIH Publication; 1995: 95-1468.

Miller GJ, Maude GH, Beckles GLA. Incidence of hypertension and noninsulin dependent diabetes mellitus and associated risk factors in a

rapidly developing Caribbean community: the St James survey, Trinidad.

J Epidemiol Community Health. 1996;50(5):497-504.

UKPDS 38. Tight blood pressure control and risk of macrovascular and

microvascular complications in type 2 diabetes: UK prospective diabetes

study group. BMJ. 1998; 317(7160):703-13.

James PA, Oparil S, Carter BL, Cushman WC, Dennison HC, Handler J,

et al. 2014 evidence-based guideline for the management of high blood

pressure in adults: report from the panel members appointed to the

eighth Joint National Committee (JNC 8). JAMA. 2014;311(17):1809.

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et

al. 2013 ESH/ESC guidelines for the management of arterial

hypertension: the task force for the management of arterial hypertension

of the European Society of Hypertension (ESH) and of the European

Society of Cardiology (ESC). Eur Heart J. 2013 Jul;34(28):2159-219.

American Diabetes Association. Standards of medical care-2014.

Diabetes Care. 2014 Jan;37(Suppl 1):S14-80.

Ref Yuen YH, Chang S, Chong CK, Lee SC, Critchlev JA, Chan JC. Drug

utilization in a hospital general medical outpatient clinic with particular

reference to antihypertensive and antidiabetic drugs. J Clin Pharm Ther.

;23:287-94.

Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, et al.

Preserving renal function in adults with hypertension and diabetes: a

consensus approach. National Kidney Foundation Hypertension and

Diabetes Executive Committees Working Group. Am J Kidney Dis.

;36(3):646-61.

ALLHAT Officers and Coordinators for the ALLHAT Collaborative

Research Group, The Antihypertensive and Lipid-Lowering Treatment to

Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive

patients randomized to angiotensin-converting enzyme inhibitor or

calcium channel blocker vs. diuretic: The Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA.

;288(23):2981-97

Berlowitz DR, Ash AS, Hickey EC, Glickman M, Friedman R, Kader B.

Hypertension management in patients with diabetes: the need for more

aggressive therapy. Diabetes Care. 2003;26(2):355-9.

Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano

G, et al. Guidelines for the management of arterial hypertension: the task

force for the management of arterial hypertension of the European

Society of Hypertension (ESH) and of the European Society of

Cardiology (ESC). Eur Heart J. 2007;28(12):1462-536.

Nather A, Bee CS, Huak CY, Chew JL, Lin CB, Neo S, et al.

Epidemiology of diabetic foot problems and predictive factors for limb

loss. J Diabetes Complicat. 2008;22(2):77-82.

Reiber GE. The epidemiology of diabetic foot problems. Diabet Med.

;13(Suppl 1):S6-11.

Shah J, Khakhkhar T, Bhirud S, Shah RB, Date S. Study of utilization

pattern of antihypertensive drugs in hypertensive diabetic patients with

or without reduced renal function at tertiary care teaching hospital. Int J

Med Sci Public Health. 2013;2:175-80.

Dhanaraj E, Raval A, Yadav R, Bhansali A, Tiwari P. Prescription pattern

of antihypertensive agents in T2DM patients visiting tertiary care centre

in North India. Int J Hypertens. 2012;2012:520915.

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of

an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular

events in high-risk patients. The heart outcomes prevention evaluation

study investigators. New Engl J Med. 2000;342(3):145-53

Sweileh WM, Sawalha AF, Zyoud SH, Al-Jabi SW, Tameem EJ. Patterns

of antihypertensive therapy in diabetic patients with and without reduced

renal function. Saudi J Kidney Dis Transpl. 2010;21:652-9.

Johnson M, Singh H. Patterns of antihypertensive therapies among

patients with diabetes. J G Intern Med. 2005;20(9):842-6.

Ashfaq T, Anjum Q, Siddiqui H, Shaikh S, Vohra EA. Awareness about

hypertension among patients attending primary health care centre and

outpatient department of tertiary care hospital of Karachi. J Pak Med

Assoc. 2007;57(8):396-9.

Downloads

Published

07.04.2024

Issue

Section

ORIGINAL ARTICLES ~ General Medicine

Similar Articles

1-10 of 143

You may also start an advanced similarity search for this article.